MicroRNA reexpression as differentiation therapy in cancer

Journal of Clinical Investigation

Volumn 119, Issue 8, 2009, Pages 2119-2123

  Mishra, Prasun J ^a   Merlino, Glenn ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA MIR 1; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; GENE EXPRESSION; GENE THERAPY; HUMAN; NEOPLASM; NOTE; ONCOGENE; PRIORITY JOURNAL; RHABDOMYOSARCOMA; RNA INTERFERENCE; SKELETAL MUSCLE;

ANIMALS; CELL DIFFERENTIATION; HUMANS; MICE; MICRORNAS; MUSCLE, SKELETAL; NEOPLASMS; ORGAN SPECIFICITY; PROTO-ONCOGENE PROTEINS C-MET; RHABDOMYOSARCOMA;

EID: 68849083270     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI40107     Document Type: Note

References (34)

1. He, L., and Hannon, G.J. 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5:522-531.
2. Mishra, P.J., and Bertino, J.R. 2009. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics. 10:399-416.
3. Lim, L.P., et al. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 433:769-773.
4. Chuang, J.C., and Jones, P.A. 2007. Epigenetics and microRNAs. Pediatr. Res. 61:24R-29R.
5. Calin, G.A., and Croce, C.M. 2006. MicroRNA signatures in human cancers. Nat. Rev. Cancer. 6:857-866.
6. Kumar, M.S., Lu, J., Mercer, K.L., Golub, T.R., and Jacks, T. 2007. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat. Genet. 39:673-677.
7. Garzon, R., Fabbri, M., Cimmino, A., Calin, G.A., and Croce, C.M. 2006. MicroRNA expression and function in cancer. Trends Mol. Med. 12:580-587.
8. Zhang, B., Pan, X., Cobb, G.P., and Anderson, T.A. 2007. microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302:1-12.
9. Hammond, S.M. 2006. MicroRNAs as oncogenes. Curr. Opin. Genet. Dev. 16:4-9.
10. Negrini, M., Ferracin, M., Sabbioni, S., and Croce, C.M. 2007. MicroRNAs in human cancer: from research to therapy. J. Cell Sci. 120:1833-1840.
11. Silber, J., et al. 2008. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 6:14.
12. Taulli, R., et al. 2009. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J. Clin. Invest. 119:2366-2378.
13. Wachtel, M., et al. 2006. Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry. J. Clin. Oncol. 24:816-822.
14. Garofalo, M., Condorelli, G., and Croce, C.M. 2008. MicroRNAs in diseases and drug response. Curr. Opin. Pharmacol. 8:661-667.
15. Fabbri, M., et al. 2007. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U. S. A. 104:15805-15810.
16. Wang, H., et al. 2008. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell. 14:369-381.
17. Ciarapica, R., et al. 2009. Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle. 8:172-175.
18. Merlino, G., and Khanna, C. 2007. Fishing for the origins of cancer. Genes Dev. 21:1275-1279.
19. Merlino, G., and Helman, L.J. 1999. Rhabdomyosarcoma - working out the pathways. Oncogene. 18:5340-5348.
20. Chen, J.F., et al. 2006. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38:228-233.
21. McCarthy, J.J. 2008. MicroRNA-206: the skeletal muscle-specific myomiR. Biochim. Biophys. Acta. 1779:682-691.
22. Nasser, M.W., et al. 2008. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem. 283:33394-33405.
23. Datta, J., et al. 2008. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 68:5049-5058.
24. Mishima, Y., et al. 2009. Zebrafish miR-1 and miR-133 shape muscle gene expression and regulate sarcomeric actin organization. Genes Dev. 23:619-632.
25. Rao, P.K., Kumar, R.M., Farkhondeh, M., Baskerville, S., and Lodish, H.F. 2006. Myogenic factors that regulate expression of muscle-specific micro-RNAs. Proc. Natl. Acad. Sci. U. S. A. 103:8721-8726.
26. Sharp, R., et al. 2002. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nat. Med. 8:1276-1280.
27. Anastasi, S., et al. 1997. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation. J. Cell Biol. 137:1057-1068.
28. Adams, B.D., Cowee, D.M., and White, B.A. 2009. The role of miR-206 in the epidermal growth factor (EGF) induced repression of estrogen receptoralpha (ER{alpha}) signaling and a luminal phenotype in MCF-7 breast cancer cells. Mol. Endocrinol. Online publication ahead of print. doi:10.1210/me.2009- 0062.
29. Wurdinger, T., and Costa, F.F. 2007. Molecular therapy in the microRNA era. Pharmacogenomics J. 7:297-304.
30. Bumcrot, D., Manoharan, M., Koteliansky, V., and Sah, D.W. 2006. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2:711-719.
31. Wang, V., and Wu, W. 2009. MicroRNA-based therapeutics for cancer. BioDrugs. 23:15-23.
32. Mishra, P.J. 2009. MicroRNA polymorphisms: a giant leap towards personalized medicine. Personalized Medicine. 6:119-125. doi:10.2217/17410541.6.2.119.
33. Ohno, R., et al. 1993. Multi-institutional study of all-trans-retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukaemia Study Group of the Ministry of Health and Welfare. Leukemia. 7:1722-1727.
34. Labourier, E., et al. 2009. microRNAs as potential diagnostic and prognostic markers of disease. http://www.ambion.com/techlib/posters/ miRNA-0405.html.